Oral tolerance is a long held observation that oral antigen results in systemic hypo-responsiveness. Recently, there is increased interest in oral tolerance following the demonstration that orally administered antigen can suppress several animal models of autoimmune disease. In addition, the oral administration of autoantigen is being tested in human autoimmune diseases and in transplantation. Nonetheless, a great deal remains to be learned about the basic mechanisms that underlie immune responses in the gut associated lymphoid tissues (GALT). Effector mechanisms of immune tolerance induced by oral antigen have been defined and relate to dose of protein fed. Low doses of protein favor induction of regulatory T cells that secrete Th2 cytokines and TGF-beta whereas higher doses induce anergy or deletion. The inductive events, however, that govern the generation of oral tolerance are not well understood and investigation of the inductive events in oral tolerance is the focus of this grant application. Based on our preliminary data we hypothesize that multiple factors contribute to the induction of regulatory cells in the GALT that mediate low dose oral tolerance including the unique micro-environment (cytokine milieu) in the gut, specialized antigen presenting cells (most likely B cells) that handle incoming antigen and the predominant expression of B7.2 on GALT antigen presenting cells. We also propose that these factors promote low affinity interactions between peptide-MHC-TCR leading to preferential generation of TGF-beta and Th2 responses. Feeding higher doses results in deletion or anergy in the GALT and at higher doses antigen leaks in the bloodstream and induces systemic tolerance. In our investigations, we will study altered peptides, which vary in their affinity for the TCR or MHC and will provide unique tools to address the issue of peptide-MHC-TCR affinity in the induction of oral tolerance. This together with studying oral tolerance in B-less mice and altering the expression of costimulatory molecules (B7.1 or B7.2) will allow us to define the role antigen, antigen presenting cells and costimulatory molecules in the inductive limb of oral tolerance. Thus the three specific aims of our proposal are: 1) How does the affinity of a peptide for binding to MHC II or the TCR affect the induction of regulatory cells following oral antigen administration? 2) What is the role of B cells in the induction of oral tolerance? and 3) What is the role of costimulation in the induction of oral tolerance? Addressing these questions will provide basic information regarding mechanisms of the induction or oral tolerance and immune responses in the gut associated lymphoid tissue.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI043458-04
Application #
6373887
Study Section
Immunological Sciences Study Section (IMS)
Program Officer
Johnson, David R
Project Start
1998-06-01
Project End
2003-04-30
Budget Start
2001-05-01
Budget End
2002-04-30
Support Year
4
Fiscal Year
2001
Total Cost
$314,925
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Rezende, Rafael M; Lanser, Amanda J; Rubino, Stephen et al. (2018) ?? T cells control humoral immune response by inducing T follicular helper cell differentiation. Nat Commun 9:3151
Kuhn, Chantal; Rezende, Rafael Machado; M'Hamdi, Hanane et al. (2017) IL-6 Inhibits Upregulation of Membrane-Bound TGF-? 1 on CD4+ T Cells and Blocking IL-6 Enhances Oral Tolerance. J Immunol 198:1202-1209
Liu, Shirong; da Cunha, Andre Pires; Rezende, Rafael M et al. (2016) The Host Shapes the Gut Microbiota via Fecal MicroRNA. Cell Host Microbe 19:32-43
Mayo, Lior; Cunha, Andre Pires Da; Madi, Asaf et al. (2016) IL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammation. Brain 139:1939-57
da Cunha, Andre P; Wu, Henry Y; Rezende, Rafael M et al. (2015) In vivo anti-LAP mAb enhances IL-17/IFN-? responses and abrogates anti-CD3-induced oral tolerance. Int Immunol 27:73-82
Levy Barazany, H; Barazany, D; Puckett, L et al. (2014) Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE. Exp Neurol 255:63-70
Rezende, Rafael M; Oliveira, Rafael P; Medeiros, Samara R et al. (2013) Hsp65-producing Lactococcus lactis prevents experimental autoimmune encephalomyelitis in mice by inducing CD4+LAP+ regulatory T cells. J Autoimmun 40:45-57
Murugaiyan, Gopal; Beynon, Vanessa; Pires Da Cunha, Andre et al. (2012) IFN-? limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27. J Immunol 189:5277-83
Mayo, Lior; Quintana, Francisco J; Weiner, Howard L (2012) The innate immune system in demyelinating disease. Immunol Rev 248:170-87
Mittal, Akanksha; Murugaiyan, Gopal; Beynon, Vanessa et al. (2012) IL-27 induction of IL-21 from human CD8+ T cells induces granzyme B in an autocrine manner. Immunol Cell Biol 90:831-5

Showing the most recent 10 out of 51 publications